Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. (SEHK:2289) from a group of shareholders for approximately HKD 250 million on January 17, 2023. The transaction is expected to close on February 10, 2023. Guotai Junan Capital Limited acted as financial advisor to Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. and Merdeka Corporate Finance Limited acted as fairness opinion provider and financial advisor to Charmacy Pharmaceutical Co., Ltd. Rodney Teoh of Stevenson Wong & Co acted as legal advisor for Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.88 HKD | -0.14% | -0.72% | +7.10% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.10% | 192M | |
-34.16% | 14.83B | |
-24.55% | 12.04B | |
-25.24% | 6.52B | |
+14.96% | 6.44B | |
-8.01% | 6.15B | |
-2.34% | 4.64B | |
+60.00% | 4.62B | |
-8.10% | 3.93B | |
-11.16% | 3.49B |
- Stock Market
- Equities
- 2289 Stock
- News Charmacy Pharmaceutical Co., Ltd.
- Jiangxi Jiangzhong Pharmaceutical Commercial Operation Co., Ltd. made an offer to acquire additional 32.12963% stake in Charmacy Pharmaceutical Co., Ltd. from a group of shareholders for approximately HKD 250 million.